Výsledky vyhledávání - "Pieter Drost"

Akademický článek

Costo efectividad de Abatacept en comparación con otras terapias biológicas para el tratamiento de la artritis reumatoide moderada a severamente activa en pacientes que han fallado al tratamiento con metotrexato en EsSalud para el año 2010

Autor: Felipe Becerra Rojas, César Benites Chacaltana, Eleonora Aiello, Carolina Zingoni, Gert Bergman, Pieter Drost, César Sanabria Montañez

Publikováno v: Acta Médica Peruana, Vol 28, Iss 4 (2024)

Objetivo: Estimar la costo efectividad de Abatacept combinado con Metotrexato (MTX) en comparación a otras DARMEs biológicas, en combinación con MTX, en pacientes con AR moderada a severamente activa. Materiales y métodos: Se adaptó un modelo

Externí odkaz: https://doaj.org/article/27879cce718447e19f4c6f2f0867be78

Zobrazit plný text záznamu

Indirect treatment comparison of abatacept with methotrexate versus other biologic agents for active rheumatoid arthritis despite methotrexate therapy in the United kingdom

Autor: L. Pericleous, Pieter Drost, Gert Bergman, Peter C. Taylor, Robin Christensen, Indra Eijgelshoven, Patricia Guyot, M. Lebmeier

Objective.To compare the efficacy of abatacept and alternative biologic disease-modifying antirheumatic drugs (DMARD) in patients with rheumatoid arthritis (RA) and an inadequate response to methotrexate (MTX) in the United Kingdom.Methods.A systemat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db38b33ef4f614d85a78210065986a2e
https://doi.org/10.3899/jrheum.111345

Zobrazit plný text záznamu

The efficacy and safety of oral anticoagulants in warfarin-suitable patients with nonvalvular atrial fibrillation: systematic review and meta-analysis

Autor: Michelle Orme, David Jakouloff, Teresa A. Simon, Syed Tasleem Raza, Stephen Mitchell, Pieter Drost, Ian Lockhart

Publikováno v: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 19(6)

The novel oral anticoagulants (NOACs) apixaban, dabigatran, and rivaroxaban have been recently indicated for stroke prevention in patients with atrial fibrillation (AF) . Due to a lack of direct head-to-head trials comparing the NOACs, the current sy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3128b37a5f2dc6d15409d3248fee90e
https://pubmed.ncbi.nlm.nih.gov/23698729

Zobrazit plný text záznamu

The efficacy and safety of pharmacological prophylaxis of venous thromboembolism following elective knee or hip replacement: systematic review and network meta-analysis

Autor: Stephen Mitchell, Pieter Drost, Nick Marchant, Dale Rublee, Alex J. Sutton, Alexander T. Cohen, Michelle Orme, Teresa A. Simon

Publikováno v: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 18(6)

The present systematic review was conducted to assess the efficacy and safety of apixaban versus other anticoagulants, for the prevention of venous thromboembolism (VTE) following total hip replacement (THR) and total knee replacement (TKR) surgery.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d58c285a0affddc05cd85ecbaf33ff18
https://pubmed.ncbi.nlm.nih.gov/22387582

Zobrazit plný text záznamu

PMS79 Mixed Treatment Comparison of Biologic Agents in Patients with Rheumatoid Arthritis Who Have responded Inadequately to Methotrexate Therapy in the United Kingdom

Autor: P Guyot, Peter C. Taylor, Gert Bergman, L. Pericleous, I Eijgelshoven, R Christensen, Pieter Drost, M. Lebmeier

Publikováno v: Value in Health. 14:A317

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d31c91e3daa968c69152adec5f82352
https://doi.org/10.1016/j.jval.2011.08.465

Zobrazit plný text záznamu

PMS33 COST EFFECTIVENESS OF ABATACEPT IN COMPARISON WITH OTHER BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS PATIENTS WHO HAVE FAILED TO METHOTREXATE BASED TREATMENT AT ESSALUD IN 2010

Autor: C. Sanabria Montañez, E. Aiello, J.E. Valencia, Gert Bergman, Pieter Drost, C. Benites Chacaltana, Carolina Zingoni, F. Becerra Rojas

Publikováno v: Value in Health. 14:A129

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5259cdcc1b4e5e7aaa5bde2dd516fa9
https://doi.org/10.1016/j.jval.2011.02.718

Zobrazit plný text záznamu

PMS71 INDIRECT TREATMENT COMPARISON TO COMPARE EFFICACY IN HEALTH ASSESSMENT QUESTIONNAIRE (HAQ) SCORE FOR BIOLOGIC AGENTS WITH METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ACTIVE DISEASE DESPITE METHOTREXATE THERAPY

Autor: Peter C. Taylor, M. Lebmeier, G Bergman, Pieter Drost, L. Pericleous, H Baig, R Christensen, P Guyot

Publikováno v: Value in Health. 13:A316

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::801952bc347d83bc3abc353618fa60c0
https://doi.org/10.1016/s1098-3015(11)72224-0

Zobrazit plný text záznamu

PMS37 THE COST-EFFECTIVENESS OF ABATACEPT IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF PATIENT WITH ACTIVE RHEUMATOID ARTHRITIS AFTER AN INADEQUATE RESPONSE TO METHOTREXATE IN THE UNITED KINGDOM

Autor: H Baig, P Dequen, L. Pericleous, Pieter Drost, M. Lebmeier, G Bergman, Mario Ouwens

Publikováno v: Value in Health. 13:A309

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2181435bc9b40622ea4745db7935beba
https://doi.org/10.1016/s1098-3015(11)72190-8

Zobrazit plný text záznamu

Akademický článek

The Efficacy and Safety of Pharmacological Prophylaxis of VTE Following Elective Knee or Hip Replacement: Systematic Review and Network Meta-Analysis

Autor: Cohen, Ander ^*, Pieter, Drost ^*, Marchant, Nick ^*, Mitchell, Stephen ^*, Orme, Michelle ^*, Simon, Teresa ^*, Sutton, Alex ^*, Rublee, Dale ^*

Publikováno v: In Blood 18 November 2011 118(21):2314-2314

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání